Success Metrics

Clinical Success Rate
100.0%

Based on 7 completed trials

Completion Rate
100%(7/7)
Active Trials
1(11%)
Results Posted
0%(0 trials)

Phase Distribution

Ph phase_4
4
44%
Ph not_applicable
5
56%

Phase Distribution

0

Early Stage

0

Mid Stage

4

Late Stage

Phase Distribution9 total trials
Phase 4Post-market surveillance
4(44.4%)
N/ANon-phased studies
5(55.6%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

100.0%

7 of 7 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

1

trials recruiting

Total Trials

9

all time

Status Distribution
Active(1)
Completed(7)
Other(1)

Detailed Status

Completed7
Recruiting1
unknown1

Development Timeline

Analytics

Development Status

Total Trials
9
Active
1
Success Rate
100.0%
Most Advanced
Phase 4

Trials by Phase

Phase 44 (44.4%)
N/A5 (55.6%)

Trials by Status

completed778%
recruiting111%
unknown111%

Recent Activity

Clinical Trials (9)

Drug Details

Intervention Type
PROCEDURE
Total Trials
9